Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-012609
Filing Date
2014-03-13
Accepted
2014-03-13 16:30:29
Documents
1
Period of Report
2014-03-11

Document Format Files

Seq Description Document Type Size
1 2014 NON-EMPLOYEE DIRECTOR GRANT rrd405482.html 4  
1 2014 NON-EMPLOYEE DIRECTOR GRANT rrd405482.xml 4 11553
  Complete submission text file 0001181431-14-012609.txt   13173
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Ekman Lars (Reporting) CIK: 0001376117 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 14691379